The Next Era of Gene Editing Will Be Disease Agnostic
A single disease-agnostic gene-editing strategy could treat many unrelated rare genetic diseases, addressing the impracticality of developing bespoke therapies for thousands of conditions.
In a World First, CRISPR Drug Tailored for One Baby Shows Life-Saving Promise
CRISPR technology successfully healed a newborn with a rare genetic disorder, indicating a breakthrough in personalized gene therapy for genetic diseases.